Alplaus, NY
lenalid 25mg (Lenalidomide) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).
Show more
Be the first to leave a review for Lenalid 25mg.